Search research articles
Contact Us
Filters
Showing results (401-410 of 515) with videos related to
Page
of 52
Sort By:
Nature Communications
|
July 1, 2017
CIB2 interacts with TMC1 and TMC2 and is essential for mechanotransduction in auditory hair cells
Arnaud P J Giese, Yi-Quan Tang, Ghanshyam P Sinha, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 28, 2021
Management of suboptimal response to induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Re-induction therapy or direct to Radiotherapy?
Ting Liu, Li-Ting Liu, Jie-Yi Lin, et al.
Cell Death & Disease
|
July 2, 2025
AK4 promotes nasopharyngeal carcinoma metastasis and chemoresistance by activating NLRP3 inflammatory complex
Sai-Lan Liu, Li Yuan, Xue-Song Sun, et al.
Plos One
|
August 28, 2015
Is Hemoglobin Level in Patients with Nasopharyngeal Carcinoma Still a Significant Prognostic Factor in the Era of Intensity-Modulated Radiotherapy Technology?
Shan-Shan Guo, Lin-Quan Tang, Qiu-Yan Chen, et al.
BMC Cancer
|
September 13, 2019
Maximal standard uptake values of <sup>18</sup>F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients
Xue-Song Sun, Yu-Jing Liang, Sai-Lan Liu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2015
New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification system
Rui You, Xiong Zou, Shun-Lan Wang, et al.
Cancer Research and Treatment
|
January 18, 2019
Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance
Xue-Song Sun, Yu-Jing Liang, Sai-Lan Liu, et al.
BMC Cancer
|
January 23, 2019
Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy
Xue-Song Sun, Li-Ting Liu, Sai-Lan Liu, et al.
The Oncologist
|
June 27, 2025
Anti-PD-1 antibody with or without capecitabine as maintenance therapy after first-line therapy of recurrent or metastatic nasopharyngeal carcinoma
Yi-Fu Li, Yu Chen, Hui Cheng, et al.
Circulation Research
|
February 25, 2026
TMC6 Is a Novel Therapeutic Target for Pathogenic Cardiac Hypertrophy
Hongkun Wang, Zongkuai Yang, Birou Zhong, et al.
Page
of 52
Search research articles
Search
Showing results (401-410 of 515) with videos related to
Sort By:
Page
of 52
Nature Communications
|
July 1, 2017
CIB2 interacts with TMC1 and TMC2 and is essential for mechanotransduction in auditory hair cells
Arnaud P J Giese, Yi-Quan Tang, Ghanshyam P Sinha, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
August 28, 2021
Management of suboptimal response to induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Re-induction therapy or direct to Radiotherapy?
Ting Liu, Li-Ting Liu, Jie-Yi Lin, et al.
Cell Death & Disease
|
July 2, 2025
AK4 promotes nasopharyngeal carcinoma metastasis and chemoresistance by activating NLRP3 inflammatory complex
Sai-Lan Liu, Li Yuan, Xue-Song Sun, et al.
Plos One
|
August 28, 2015
Is Hemoglobin Level in Patients with Nasopharyngeal Carcinoma Still a Significant Prognostic Factor in the Era of Intensity-Modulated Radiotherapy Technology?
Shan-Shan Guo, Lin-Quan Tang, Qiu-Yan Chen, et al.
BMC Cancer
|
September 13, 2019
Maximal standard uptake values of <sup>18</sup>F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients
Xue-Song Sun, Yu-Jing Liang, Sai-Lan Liu, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2015
New surgical staging system for patients with recurrent nasopharyngeal carcinoma based on the AJCC/UICC rTNM classification system
Rui You, Xiong Zou, Shun-Lan Wang, et al.
Cancer Research and Treatment
|
January 18, 2019
Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance
Xue-Song Sun, Yu-Jing Liang, Sai-Lan Liu, et al.
BMC Cancer
|
January 23, 2019
Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy
Xue-Song Sun, Li-Ting Liu, Sai-Lan Liu, et al.
The Oncologist
|
June 27, 2025
Anti-PD-1 antibody with or without capecitabine as maintenance therapy after first-line therapy of recurrent or metastatic nasopharyngeal carcinoma
Yi-Fu Li, Yu Chen, Hui Cheng, et al.
Circulation Research
|
February 25, 2026
TMC6 Is a Novel Therapeutic Target for Pathogenic Cardiac Hypertrophy
Hongkun Wang, Zongkuai Yang, Birou Zhong, et al.
Page
of 52